TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 348 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $365,740 | -7.8% | 25,630 | 0.0% | 0.03% | -23.7% |
| Q3 2023 | $396,496 | -1.5% | 25,630 | 0.0% | 0.04% | +18.8% |
| Q2 2023 | $402,647 | -4.7% | 25,630 | 0.0% | 0.03% | -15.8% |
| Q1 2023 | $422,382 | +5.6% | 25,630 | 0.0% | 0.04% | +2.7% |
| Q4 2022 | $399,828 | +20.4% | 25,630 | 0.0% | 0.04% | +8.8% |
| Q3 2022 | $332,000 | -7.8% | 25,630 | 0.0% | 0.03% | -19.0% |
| Q2 2022 | $360,000 | -1.9% | 25,630 | 0.0% | 0.04% | +31.2% |
| Q1 2022 | $367,000 | +5.2% | 25,630 | 0.0% | 0.03% | +28.0% |
| Q4 2021 | $349,000 | -16.9% | 25,630 | 0.0% | 0.02% | -10.7% |
| Q3 2021 | $420,000 | -2.6% | 25,630 | 0.0% | 0.03% | +7.7% |
| Q2 2021 | $431,000 | -91.2% | 25,630 | -90.9% | 0.03% | -96.5% |
| Q3 2019 | $4,871,000 | -33.6% | 283,200 | -31.7% | 0.74% | -27.8% |
| Q2 2019 | $7,338,000 | -12.8% | 414,627 | +0.4% | 1.02% | -6.9% |
| Q1 2019 | $8,416,000 | – | 413,136 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Y.D. More Investments Ltd | 1,498,811 | $24,700,380 | 5.57% |
| TFG Asset Management GP Ltd | 1,903,662 | $31,372,350 | 4.20% |
| Clean Yield Group | 542,342 | $8,937,796 | 3.81% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,467,952 | $24,192 | 3.67% |
| Mondrian Investment Partners LTD | 4,081,715 | $67,266,663 | 1.48% |
| Sippican Capital Advisors | 82,235 | $1,355,233 | 1.30% |
| Psagot Value Holdings Ltd. / (Israel) | 174,300 | $2,830 | 1.18% |
| Clal Insurance Enterprises Holdings Ltd | 4,365,500 | $71,943 | 1.08% |
| Legacy Wealth Asset Management, LLC | 123,303 | $2,032,033 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 1,817,972 | $29,960,175 | 0.64% |